Home / Diabetes In Control (page 886)

Diabetes In Control

HOMA: Often Mentioned, Rarely Defined

I was reviewing some new studies on the use of insulin this past week and every study seemed to use HOMA values. Homeostatic model assessment (HOMA) was first used in 1985 and was derived mathematically by looking at the interaction between beta-cell function and insulin resistance of normoglycemic patients. Alexander …

Read More »

Two New Diabetes Drugs could be Approved by April 2nd

A U.S. Food and Drug Administration panel will review two proposed drugs to treat Type 2 diabetes this April. According to a meeting notice posted on the FDA’s website Monday, the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee will discuss Bristol-Myers Squibb’s saxagliptin tablets on April 1 and Novo Nordisk.’s liraglutide …

Read More »

Oral Insulin “Oral-lyn” Phase III Study Shows Positive Results

Generex Biotechnology Corporation, a leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced positive results following the review of the Phase III data for the company’s flagship product, Generex Oral-lyn, a proprietary oral insulin spray product designed to replace prandial injections of insulin.

Read More »